We proudly serve Arcadia, Pasadena, Los Angeles and the San Gabriel Valley, while our mobile IV therapy extends our care across Los Angeles County, bringing professional wellness directly to you
Certain patientssuch as those with specific types of endocrine cancersshould avoid GLP1s, he explained, and there are clear guidelines for who may benefit most, including people with diabetes, obesity or other chronic conditions that contribute to long-term weight gain
SLU-PP-332 is a novel synthetic pan-agonist of the estrogen-related receptors (ERR, ERR, ERR), originally developed at Saint Louis University and characterised in recent pre-clinical literature as an exercise mimetic. It is widely studied in research models exploring mitochondrial biogenesis, fatty-acid oxidation, and metabolic endurance
Impact of body weight dynamics following intentional weight loss on fracture risk: results from the action for health in diabetes study
Compounded tirzepatide may be provided to the patient in various forms, such as oral or injectable (more on that below)
